Benchmarking of Quantitative Proteomics Workflows for Limited Proteolysis Mass Spectrometry
Molecular & Cellular Proteomics · 2025-04 · 24 (4) · 100945
DOI: 10.1016/j.mcpro.2025.100945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025-04. Verfasst von Tomas Koudelka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. Hauptthemen laut MEDLINE: Proteomics, Proteolysis, Mass Spectrometry. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Helmholtz-Gemeinschaft, Helmholtz Association.
Abstract (Originalsprache)
Limited proteolysis coupled with mass spectrometry (LiP-MS) has emerged as a powerful technique for detecting protein structural changes and drug-protein interactions on a proteome-wide scale. However, there is no consensus on the best quantitative proteomics workflow for analyzing LiP-MS data. In this study, we comprehensively benchmarked two major quantification approaches-data-independent acquisition (DIA) and tandem mass tag (TMT) isobaric labeling-in combination with LiP-MS, using a drug-target deconvolution assay as a model system. Our results show that while TMT labeling enabled the quantification of more peptides and proteins with lower coefficients of variation, DIA-MS exhibited greater accuracy in identifying true drug targets and stronger dose-response correlation in peptides of protein targets. Additionally, we evaluated the performance of freely available (FragPipe) versus commercial (Spectronaut) software tools for DIA-MS analysis, revealing that the choice between precision (FragPipe) and sensitivity (Spectronaut) largely depends on the specific experimental context. Our findings underscore the importance of selecting the appropriate LiP-MS quantification strategy based on the study objectives. This work provides valuable guidelines for researchers in structural proteomics and drug discovery, and highlights how advancements in mass spectrometry instrumentation, such as the Astral mass spectrometer, may further improve sensitivity and protein sequence coverage, potentially reducing the need for TMT labeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden. Electronic address: i…
Förderung
- European Research Council
- Helmholtz-Gemeinschaft
- Helmholtz Association
- Horizon 2020 Framework Programme
- German Research Foundation
Zitieren
APA
Koudelka, T., Bassot, C., & Piazza, I. (2025). Benchmarking of Quantitative Proteomics Workflows for Limited Proteolysis Mass Spectrometry. Molecular & Cellular Proteomics, 24(4), 100945. https://doi.org/10.1016/j.mcpro.2025.100945
Vancouver
Koudelka T, Bassot C, Piazza I. Benchmarking of Quantitative Proteomics Workflows for Limited Proteolysis Mass Spectrometry. Molecular & Cellular Proteomics. 2025;24(4):100945. doi:10.1016/j.mcpro.2025.100945
BibTeX
@article{Koudelka2025,
author = {Koudelka, Tomas and Bassot, Claudio and Piazza, Ilaria},
title = {Benchmarking of Quantitative Proteomics Workflows for Limited Proteolysis Mass Spectrometry},
journal = {Molecular & Cellular Proteomics},
year = {2025},
volume = {24},
number = {4},
pages = {100945},
doi = {10.1016/j.mcpro.2025.100945}
}
EUVIMED